Iceland· IS-IS/1/25/102/01
Candesartan STADA
A candesartan product containing candesartanum inn cílexetíl, registered in Iceland by STADA Arzneimittel AG. The same ATC class is registered in 16 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Candesartan is registered in 16 of 19 countries.
Countries holding a registration under ATC C09CA06 (candesartan), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 9 of them publish a price we can compare per daily dose
Candesartan · ATC C09CA06
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of candesartan costs, country by country.
Normalised to the WHO defined daily dose (8 mg), the median price runs from $0.15 in Italy to $0.36 in Switzerland — a ×2.3 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Candesartan · price per daily dose (8 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.36
- ES Spain$0.21
- IT Italy$0.15
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Candesartanum INN cílexetíl
- Manufacturer
- STADA Arzneimittel AG
- Country
- Iceland (IS)
- ATC code
- C09CA06
- ATC class
- Candesartan
- Defined daily dose
- 8 mg, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
81 interactions on record for candesartan.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Candesartan · interactions on record
81 records
81 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Candesartan in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1d5a833c-a1dd-43a7-a1fd-79ec0431838f GET /v1/drugs/1d5a833c-a1dd-43a7-a1fd-79ec0431838f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tafla",
"source": "lyfjastofnun",
"atc_raw": "C09CA06",
"marketed": false,
"strength": "4 mg",
"ma_number": "IS/1/25/102/01",
"substance": "Candesartanum INN cílexetíl",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "45869"
}See everything about candesartan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.